
Press and Media
RMDM Group is a UK-based one-stop-shop for cancer diagnostics, prevention and treatment. We use ground-breaking technology to provide healthcare partners worldwide with non-invasive, low cost and highly accurate early intervention diagnostic tools.
Business Overview
Established in 2017, RMDM is founded on the principles of the pioneering work of Dr Johannes Coy, who discovered the TKTL1 gene. Our purpose is to harness the power of cutting-edge research and technology to provide practical and affordable interventions to support health and wellbeing, focusing particularly on diagnostics and metabolism. The revolutionary PanTum Detect test is one such example.
Through our commitment to rigorous research and scientific collaboration, we work to translate evidence into practice in a way that positively disrupts the health and wellbeing industry.
Multimedia
TalkRadio Live Interview
December 2020
Sky Radio Live Interview
December 2020
Big City Radio Live
December 2020
BBC Essex Live Interview
December 2020
Radio News Hub Live
December 2020
RMDM Group in the News
Health Tech Digital
Med-Tech Innovation
TotalHealth
Downloads
PanTum Detect is available at the following locations
Useful Links
Media Newsletter
Media related enquiries
For all enquiries please use the contact form below.